Cargando...
Oral itraconazole for epistaxis in hereditary hemorrhagic telangiectasia: a proof of concept study
The inhibiting effects of itraconazole, an antifungal drug on vascular endothelial growth factor (VEGF) have recently been discovered. By inhibiting VEGF, itraconazole has shown potential in clinical trials as anti-cancer treatment. In hereditary hemorrhagic telangiectasia (HHT) patients, VEGF level...
Gardado en:
| Publicado en: | Angiogenesis |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7615075/ https://ncbi.nlm.nih.gov/pubmed/33211216 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10456-020-09758-2 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|